U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474467) titled 'Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars' on March 11.
Brief Summary: The purpose of this clinical trial was to evaluate the safety and efficacy of a single administration of TRTP-101 in adults with atrophic scars.
Study Start Date: Aug. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Atrophic Scar
Intervention:
BIOLOGICAL: TRTP-101
Intradermal injection
BIOLOGICAL: Placebo
Intradermal injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: CellinCells
Published by HT Digital Content Services with permission from Health Daily Digest....